Navigation Links
Large Vein Occlusive Disease: Diagnosis and Treatment Options to be Presented at the 40th Annual VEITHsymposium in New York
Date:11/20/2013

NEW YORK, Nov. 20, 2013 /PRNewswire-iReach/ -- Large vein occlusive disease is on the rise, especially in diabetic patients.  Management of deep vein thrombosis (DVT) of the upper extremity due to thoracic outlet syndrome compressing the subclavian vein and of the lower extremity due to iliac vein stenosis remains controversial.  Media is invited to attend any and all presentations relative to large vein occlusive disease presented at the 40th Annual VEITHsymposium in New York. The session will commence on Thursday, November 21st, 1:00 P.M. to 5:00 P.M. located in Americas Hall I, 3rd Floor of the New York Hilton-Midtown (NY, NY). Kenneth Ouriel, MD, MBA, FACS, FACC will moderate the session.

    Dr. Ouriel said, "This session will be particularly interesting to the media.  We will discuss state-of-the-art diagnostic and treatment modalities for large vein occlusion in the upper and lower extremities.  Therapy for axillo/subclavian and lower extremity venous stenotic and occlusive disease continues to evolve, with accumulating data on pharmacologic, mechanical, and open surgical modalities. There is much to be learned."  Media will have an opporunity to interview presenters in the VEITHsymposium press office. 

     The recent advent of stents engineered specifically for the venous anatomy and physiology provides a timely setting to discuss the indications and early outcome of endovascular therapy for venous occlusion.  Lastly, clinicians who are highly skilled in these demanding procedures will present the indications and operative techniques for major open surgical reconstruction of the vena cava and other large veins. 

     Ouriel concluded, "In short, accumulating data on large vessel venous occlusion affords opportunities for the patient and the vascular practitioner alike.  Newly gained knowledge of the disease and the results of treatment can be applied to a larger proportion of the underserved population with venous disease; at the same time expanding the armamentarium of effective interventions available to the practicing clinician."  

     Experts will address the unmet needs and opportunities for the future, other commonly encountered venous occlusive problems and their treatment, treatment of lower extremityDVT, balloons, stents, thrombolysis, ultrasound thrombolysis, mechanical thrombectomy, and inferior vena caval issues (including endovascular and open surgical management). 

     About VEITHsymposium: Now in its fourth decade, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features over 750 rapid-fire presentations from world-renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. To register to attend the VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780 or email.

Media Contact: Pauline Mayer, PTM Healthcare Marketing, Inc., 631-979-3780, ptm@ptmhcm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE VEITHsymposium
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ViGene Biosciences Introduces Worlds Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
2. Does Your Business Have the Tools to Compete in the Worlds Largest Diagnostics Markets?
3. Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013
4. DNA Diagnostics Center (DDC), One of the Worlds Largest DNA Testing Companies, Increases the Identification Power of its DNA Tests by More Than 500%
5. B. Braun Receives FDA Approval For New Large-Volume Irrigation Containers
6. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
7. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
8. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
9. Large-Scale Global Registry to Examine Treatment Patterns and Disease Burden Among Patients with Venous Thromboembolism (VTE)
10. SERVE-HF; the Worlds Largest Study of Sleep-Disordered Breathing in Heart Failure Completes Recruitment
11. Large-Scale Kaiser Permanente Program Linked to Improved Blood Pressure Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... The Institute for In Vitro Sciences (IIVS), ... of a VITROCELL® inhalation exposure system thanks to a ... device, which is designed to replace animals in inhalation ... to airborne test materials in an environment that mimics ... for testing combustible tobacco products, as well as next ...
Breaking Medicine Technology:
(Date:7/23/2017)... , ... July 23, 2017 , ... ... announce today the grant of US Patent No. 9,038,640 by the United States ... technology and brings together the combination of Switching, Vacuum, and Cooling mechanisms to ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... services to families and business owners in the Dalton region, is working in ... children overcoming sexual assault and physical abuse. , The GreenHouse is headquartered in ...
(Date:7/21/2017)... ... July 21, 2017 , ... Adolfson ... renovate and improve the Ramsey County Medical Examiners Facility located in Saint Paul, ... $2.5 million project is scheduled to start in late 2017/early 2018. , ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... The Margarian ... falsely advertising the contents of its ginger ale for allegedly containing no ginger. Dr. ... Dr. Pepper Snapple Group, Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® Water ... population and the greatest number of sufferers of blindness. “We think that Nature’s ...
Breaking Medicine News(10 mins):